ckd semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Novo Nordisk's semaglutide shows promise

Die Kapseln sind, wie alle unsere Produkte, frei von genmodifizierten Inhaltsstoffen, sowie Farb- und Aromastoffen

Conclusion Oral semaglutide is a genuine and meaningful addition to the management of type 2 diabetes, particularly for patients who have strong reasons to avoid injections

Nat Med 21:2736 Wang Y, Du J, Zou H et al (2016) Multifunctional antibody agonists targeting glucagon-like peptide-1, glucagon, and glucose-dependent insulinotropic polypeptide receptors

In this brief review, we shall discuss recent important evidences of the potential clinical benefit of the incretin effect on cardiovascular system as well as the biological mechanisms, which underlie these effects